Found 146 will-simon trials
A listing of will-simon medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
ARE YOU A BREAST CANCER SURVIVOR? Join Our Study and Help Researchers Learn More About Treating Cognitive Problems Attributed to Chemotherapy
B
Brenna McDonald
ARE YOU A BREAST CANCER SURVIVOR? HAVE YOU NOTICED ANY PROBLEMS WITH YOUR COGNITIVE FUNCTION - MEMORY, ATTENTION, ABILITY TO MULTI-TASK - AFTER COMPLETING CHEMOTHERAPY? Researchers at Indiana University School of Medicine and the University of Pittsburgh are seeking volunteers to take part in a study looking at two …
TheraSphere With Durvalumab and Tremelimumab for HCC (ROWAN)
P
Paul Haste
Phase 2
The objective of the ROWAN clinical study is to assess the efficacy of local tumor control in HCC patients who receive TheraSphere followed by durvalumab and tremelimumab.
ARX517 in Subjects With Advanced Solid Tumor (ARX517)
N
Nabil Adra, MD
Phase 1
A Phase 1, Multicenter, Open-label, Dose-escalation, and Dose expansion Study to Evaluate they, Pharmacokinetics, and Anti-tumor Activity of ARX517 in Subjects with Advanced Solid Tumor with known PSMA Who Failed Prior Standard Therapies
A COG Soft Tissue Sarcoma Biology and Banking Protocol
S
Sandeep Batra, MD
The purpose of this study is to better diagnose certain types of cancer.
Total Cancer Care: A Lifetime Partnership with Patients Who Have or May be at Risk of Having Cancer
B
Bryan Schneider, MD
The purpose of this research study is to collect and store biospecimens and personal health information to use in future research studies. This research study is to build a large database (of information and specimens) to find better ways to prevent, diagnose and treat cancer.
Cysview Blue Light Cystoscopy Registry
H
Hristos Kaimakliotis, MD
The purpose of this registry is to study the use of BLCC in clinical practice in the United States and to allow researchers access to this data to look at different clinical questions.
A first-in-human, Phase I Study to Evaluate the Safety of TTX-080, an HLA-G Antagonist, in Subjects with Advanced Solid Tumors
G
Greg Durm, MD
Phase 1
To assess the safety and tolerability of TTX-080
Dose Escalation Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors
M
Mateusz Opyrchal, MD, PhD
Phase 1
A first-in-human, Phase I, open-label, multicenter study of WTX-124 administered asherapy and in combination with pembrolizumab to patients with advanced solid tumors.
Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules (ALTITUDE)
C
Catherine Sears, MD
This study evaluates the how addition of the Nodify XL2 test result impacts the clinicalgement of newly identified solid lung nodules assessed as low to moderate risk of cancer.
Registering Genomics and Imaging of Tumors
J
Jason Parker
This research is being done to see if genetic mutations inside brain tumors can be identified using pictures from MRI or PET scanners, instead of using needles or surgery. To conduct the study, we need to take pictures of the locations of tumor samples as they are removed during surgery. …
